Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88141769 |
LAW OFFICE ASSIGNED |
LAW OFFICE 111 |
MARK SECTION |
MARK |
CHOLESTOSOMES (see, http://uspto.report/TM/88141769/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
CHOLESTOSOMES |
OWNER SECTION (current) |
NAME |
Therasyn Sensors, Inc. |
MAILING ADDRESS |
100 Crosby Blvd |
CITY |
Buffalo |
STATE |
New York |
ZIP/POSTAL CODE |
14226-3246 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
Therasyn Sensors, Inc. |
MAILING ADDRESS |
100 Crosby Blvd |
CITY |
Buffalo |
STATE |
New York |
ZIP/POSTAL CODE |
14226-3246 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
ATTORNEY INFORMATION (current) |
NAME |
R. Neil Sudol |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
FIRM NAME |
COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C. |
STREET |
714 COLORADO AVENUE |
CITY |
BRIDGEPORT |
STATE |
Connecticut |
POSTAL CODE |
06605-1601 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
203-366-3560 |
FAX |
203-335-6779/6899 |
EMAIL |
rnsudol@cssiplaw.com |
DOCKET/REFERENCE NUMBER |
F29-020 |
ATTORNEY INFORMATION (proposed) |
NAME |
R. Neil Sudol |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C. |
STREET |
714 COLORADO AVENUE |
CITY |
BRIDGEPORT |
STATE |
Connecticut |
POSTAL CODE |
06605-1601 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
203-366-3560 |
FAX |
203-335-6779/6899 |
EMAIL |
rnsudol@cssiplaw.com |
DOCKET/REFERENCE NUMBER |
F29-020 |
CORRESPONDENCE INFORMATION (current) |
NAME |
R. NEIL SUDOL |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
rnsudol@cssiplaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
moconnell@cssiplaw.com; rnspatent@netzero.net |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
R. Neil Sudol |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
rnsudol@cssiplaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
moconnell@cssiplaw.com; rnspatent@netzero.net |
DOCKET/REFERENCE NUMBER |
F29-020 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations for Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis,
psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases
including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease,
alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus
(SLE), and ankylosing spondylitis; vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of lipids, containing and
facilitating the delivery of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and
thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or
c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin
deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing
spondylitis; vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of cholesteryl ester, containing and facilitating the
delivery of pharmaceuticals for use in the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal
injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c,
hepatic disease including non- alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin
deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), and
ankylosing spondylitis; and vaccines and vaccinations to prevent or treat infectious diseases and cancer |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
11/05/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/R. Neil Sudol/ |
SIGNATORY'S NAME |
R. Neil Sudol |
SIGNATORY'S POSITION |
Attorney for applicant, member NY State bar |
DATE SIGNED |
04/17/2020 |
SIGNATORY'S PHONE NUMBER |
203-366-3560 |
FILING INFORMATION |
SUBMIT DATE |
Fri Apr 17 13:29:33 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XXX.XXX-
20200417132933715760-8814
1769-710f458cf4ef82c15c67
6f1c1331ca154a2a785d6c467
c4eb27b986ce8fe2dae892-DA
-29333556-202004171325552
23334 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: CHOLESTOSOMES (see, http://uspto.report/TM/88141769/mark.png)
SERIAL NUMBER: 88141769
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Therasyn Sensors, Inc., having an address of
100 Crosby Blvd
Buffalo, New York 14226-3246
United States
Proposed: Therasyn Sensors, Inc., having an address of
100 Crosby Blvd
Buffalo, New York 14226-3246
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 11/05/2019.
For International Class 005:
Current identification: Pharmaceutical preparations for Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal
injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c,
hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin
deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), and
ankylosing spondylitis; vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of lipids, containing and facilitating the
delivery of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to
skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease
including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency,
hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis;
vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of cholesteryl ester, containing and facilitating the delivery of
pharmaceuticals for use in the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin
and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease
including non- alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency,
hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), and ankylosing
spondylitis; and vaccines and vaccinations to prevent or treat infectious diseases and cancer
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
The applicant's current Attorney Information:
R. Neil Sudol COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C.
714 COLORADO AVENUE
BRIDGEPORT, Connecticut 06605-1601
United States
Phone: 203-366-3560
Fax: 203-335-6779/6899
The docket/reference number is F29-020
Email: rnsudol@cssiplaw.com
The applicant's proposed Attorney Information:
R. Neil Sudol COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C.
714 COLORADO AVENUE
BRIDGEPORT, Connecticut 06605-1601
United States
Phone: 203-366-3560
Fax: 203-335-6779/6899
The docket/reference number is F29-020
Email: rnsudol@cssiplaw.com
Correspondence Information (current):
R. NEIL SUDOL
PRIMARY EMAIL FOR CORRESPONDENCE: rnsudol@cssiplaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): moconnell@cssiplaw.com; rnspatent@netzero.net
Correspondence Information (proposed):
R. Neil Sudol
PRIMARY EMAIL FOR CORRESPONDENCE: rnsudol@cssiplaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): moconnell@cssiplaw.com; rnspatent@netzero.net
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /R. Neil Sudol/ Date Signed: 04/17/2020
Signatory's Name: R. Neil Sudol
Signatory's Position: Attorney for applicant, member NY State bar
Signatory's Phone: 203-366-3560
Mailing Address:
COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C.
714 COLORADO AVENUE
BRIDGEPORT, Connecticut 06605-1601
RAM Sale Number: 88141769
RAM Accounting Date: 04/17/2020
Serial Number: 88141769
Internet Transmission Date: Fri Apr 17 13:29:33 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-202004171329337
15760-88141769-710f458cf4ef82c15c676f1c1
331ca154a2a785d6c467c4eb27b986ce8fe2dae8
92-DA-29333556-20200417132555223334